Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B-Cell Lineage Envelope Design |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-07-20 |
| Study Made Public: | 2016-02-16 |
Title
Neutralization of plasma and recombinant mAbs from RV144/RV305 patients
Description
CAVD 376 is an immunogenicity study to screen monoclonal antibodies from vaccine recipients in the human clinical trials, RV144, RV305, and RV306.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.